This condition is more likely when a mutation in
apolipoprotein E (ApoE) is present. ApoE serves as a
ligand for the
liver receptor for
chylomicrons,
IDL and
VLDL, also known as
very-low-density-lipoprotein receptor. Individuals with two copies of the ApoE2 gene have substantially elevated risk of this condition. This defect prevents the normal metabolism of chylomicrons, IDL and VLDL, otherwise known as remnants, and therefore leads to accumulation of cholesterol within scavenger cells (macrophages) to enhance development and acceleration of atherosclerosis. ==Treatment==